AI Science Tracker

Deep learning helps prioritize potent MAGL inhibitor candidates

F. Hoffmann-La Roche · 29 Jan 2025 · medicine

Discovery

Deep learning helps prioritize potent MAGL inhibitor candidates

Deep graph neural networks trained on 13,490 Minisci reaction outcomes predicted reaction feasibility for a virtual library of 26,375 compounds derived from moderate MAGL inhibitors. Combined with physicochemical and structure-based scoring, this workflow prioritized 212 candidates; 14 were synthesized and showed subnanomolar MAGL inhibition, with reported potency improvements up to 4,500-fold over the starting hit. This is an AI-assisted, human-selected laboratory optimization result, not an autonomous workflow or a therapeutic outcome.

Technology: Deep graph neural networks for reaction outcome prediction; multi-objective molecular optimization

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: Fourteen selected synthesized compounds were reported with subnanomolar MAGL inhibition and co-crystal structures for three ligands.
  • Still unknown: Independent replication, clinical activity and version 1 claim correspondence were not established.
  • AI role: Reaction-prediction models trained on high-throughput Minisci experiments contributed to candidate feasibility scoring; other computational scores and human selection also shaped the experimental set.

Evidence sources: https://www.cambridge.org/engage/chemrxiv/article-details/6798ae2881d2151a024590d5

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary ChemRxiv v2 abstract and version metadata reviewed; full manuscript and supplements not inspected..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.